Procedure Manual Appendix XI. Tool to Assess Adequacy and Certainty of Evidence for a Task Force Recommendation

  Population or Group 1 Population or Group 2
Detection
  • KQ 2. What is the test performance of screening instruments to detect this disorder in community-dwelling primary care patients?
KQ 2:
(convincing, adequate, or inadequate)
KQ 2:
(convincing, adequate, or inadequate)
Benefits – KQ Evidence
  • KQ 1. Does screening for this disorder in adults in primary care–relevant settings improve outcomes compared to later diagnosis?
  • KQ 4. Does early treatment of this screen-detected disorder improve outcomes compared to later treatment?
KQ 1:
KQ 4:
(convincing, adequate, or inadequate)
KQ 1:
KQ 4:
(convincing, adequate, or inadequate)
Benefits – Linkage Coherence (convincing, adequate, or inadequate) (convincing, adequate, or inadequate)
Benefits – Magnitude (substantial, moderate, small, zero, or cannot be determined) (substantial, moderate, small, zero, or cannot be determined)
Harms – Evidence
  • KQ 3. What are the harms of screening for this disorder?
  • KQ 5. What are the harms of early treatment for this disorder?
KQ 3:
KQ 5:
(convincing, adequate, or inadequate)
KQ 3:
KQ 5:
(convincing, adequate, or inadequate)
Harms – Linkage Coherence (convincing, adequate, or inadequate) (convincing, adequate, or inadequate)
Harms – Magnitude (substantial, moderate, small, zero, or cannot be determined) (substantial, moderate, small, zero, or cannot be determined)
Overall Certainty (high, moderate, or low) (high, moderate, or low)
Magnitude of Net Benefit
(Net Benefit = Benefits – Harms)
(substantial, moderate, small, zero, or cannot be determined) (substantial, moderate, small, zero, or cannot be determined)
GRADE (A, B, C, D, or I) (A, B, C, D, or I)

Current as of: July 2017
Internet Citation: Appendix XI. Tool to Assess Adequacy and Certainty of Evidence for a Task Force Recommendation. U.S. Preventive Services Task Force. July 2017.

Back to Previous Section

Proceed to Next Section